Cargando…
Rho‐kinase inhibitors do not expand hematoma volume in acute experimental intracerebral hemorrhage
Rho‐associated kinase (ROCK) is an emerging target in acute ischemic stroke. Early pre‐hospital treatment with ROCK inhibitors may improve their efficacy, but their antithrombotic effects raise safety concerns in hemorrhagic stroke, precluding use prior to neuroimaging. Therefore, we tested whether...
Autores principales: | Akhter, Murtaza, Qin, Tom, Fischer, Paul, Sadeghian, Homa, Kim, Hyung Hwan, Whalen, Michael J., Goldstein, Joshua N., Ayata, Cenk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989779/ https://www.ncbi.nlm.nih.gov/pubmed/29928660 http://dx.doi.org/10.1002/acn3.569 |
Ejemplares similares
-
Does the Volume and Localization of Intracerebral Hematoma Affect Short-Term Prognosis of Patients with Intracerebral Hemorrhage?
por: Salihović, Denisa, et al.
Publicado: (2013) -
Hematoma volume and other prognostic factors with mortality in spontaneous intracerebral hemorrhage
por: Rotzel, HB, et al.
Publicado: (2015) -
Location-Specific Hematoma Volume Cutoff and Clinical Outcomes in Intracerebral Hemorrhage
por: Teo, Kay-Cheong, et al.
Publicado: (2023) -
Hematoma expansion in intracerebral hemorrhage – the right target?
por: Haupenthal, David, et al.
Publicado: (2023) -
Relationship of Serum IL-12 to Inflammation, Hematoma Volume, and Prognosis in Patients With Intracerebral Hemorrhage
por: Zhang, Yazhao, et al.
Publicado: (2022)